Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kousaku Iwatsubo

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Recent Patents on Cardiovascular Drug Discovery|January 29, 2008
Therapeutic targets for heart failure: beyond beta-adrenergic and renin-angiotensin system blockadeKousaku Iwatsubo, Yoshihiro Ishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2006
[Alpha adrenergic receptor blockers for patients with hypertension]Kousaku Iwatsubo, Satoshi Umemura
Expert Opinion on Therapeutic Targets|June 5, 2003
Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapyKousaku Iwatsubo, Takashi Tsunematsu, Yoshihiro Ishikawa
Endocrine, Metabolic & Immune Disorders Drug Targets|October 5, 2006
Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signalingKousaku Iwatsubo, Satoshi Okumura, Yoshihiro Ishikawa
Pharmacological Reviews|June 19, 2013
The prostanoid EP4 receptor and its signaling pathwayUtako Yokoyama, Kousaku Iwatsubo, Masanari Umemura, et al.
Drug Metabolism Letters|April 10, 2009
cAMP-mediated regulation of CYP enzymes and its application in chemotherapyYoshihiro Ishikawa, Sayaka Suzuki, Koji Otsu, et al.
Heart Failure Reviews|July 27, 2010
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5David Ho, Lin Yan, Kousaku Iwatsubo, et al.
Journal of Molecular and Cellular Cardiology|July 25, 2003
Ischemic preconditioning prevents ischemia-induced beta-adrenergic receptor sequestrationKousaku Iwatsubo, Yoshiyuki Toya, Takayuki Fujita, et al.
American Journal of Physiology. Cell Physiology|August 7, 2009
Epac increases melanoma cell migration by a heparan sulfate-related mechanismErdene Baljinnyam, Kousaku Iwatsubo, Reiko Kurotani, et al.
Pigment Cell & Melanoma Research|May 5, 2011
Epac1 promotes melanoma metastasis via modification of heparan sulfateErdene Baljinnyam, Masanari Umemura, Mariana S De Lorenzo, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Recent Patents on Cardiovascular Drug Discovery|January 29, 2008
Therapeutic targets for heart failure: beyond beta-adrenergic and renin-angiotensin system blockadeKousaku Iwatsubo, Yoshihiro Ishikawa
Nihon Rinsho. Japanese Journal of Clinical Medicine|September 20, 2006
[Alpha adrenergic receptor blockers for patients with hypertension]Kousaku Iwatsubo, Satoshi Umemura
Expert Opinion on Therapeutic Targets|June 5, 2003
Isoform-specific regulation of adenylyl cyclase: a potential target in future pharmacotherapyKousaku Iwatsubo, Takashi Tsunematsu, Yoshihiro Ishikawa
Endocrine, Metabolic & Immune Disorders Drug Targets|October 5, 2006
Drug therapy aimed at adenylyl cyclase to regulate cyclic nucleotide signalingKousaku Iwatsubo, Satoshi Okumura, Yoshihiro Ishikawa
Pharmacological Reviews|June 19, 2013
The prostanoid EP4 receptor and its signaling pathwayUtako Yokoyama, Kousaku Iwatsubo, Masanari Umemura, et al.
Drug Metabolism Letters|April 10, 2009
cAMP-mediated regulation of CYP enzymes and its application in chemotherapyYoshihiro Ishikawa, Sayaka Suzuki, Koji Otsu, et al.
Heart Failure Reviews|July 27, 2010
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5David Ho, Lin Yan, Kousaku Iwatsubo, et al.
Journal of Molecular and Cellular Cardiology|July 25, 2003
Ischemic preconditioning prevents ischemia-induced beta-adrenergic receptor sequestrationKousaku Iwatsubo, Yoshiyuki Toya, Takayuki Fujita, et al.
American Journal of Physiology. Cell Physiology|August 7, 2009
Epac increases melanoma cell migration by a heparan sulfate-related mechanismErdene Baljinnyam, Kousaku Iwatsubo, Reiko Kurotani, et al.
Pigment Cell & Melanoma Research|May 5, 2011
Epac1 promotes melanoma metastasis via modification of heparan sulfateErdene Baljinnyam, Masanari Umemura, Mariana S De Lorenzo, et al.
Pageof 4